Current reporting, research and professional developments across Clinical Psychology, curated for psychologists and behavioral-health professionals.
New research shows that pairing the decades-old antipsychotic chlorpromazine with the mitochondrial fission inhibitor mdivi-1 sharply boosts cancer cell death in liver and breast cancer models by ...
BROOKLYN, New York, October 5, 2026 — David Tzall, PsyD, a licensed clinical psychologist based in Brooklyn, is urging couples to be cautious about turning to AI chatbots to work through relationship ...
“Our main takeaway is that among people with depression, those using psilocybin aren't abandoning conventional mental health care, which is good news," said lead researcher Avery Eun, a second-year ...
In this Sportsing Short, Ian McCall breaks down the ongoing clash between psychedelic therapy and traditional Western medicine. Ian discusses why the conversation has become so polarized, how ...
The Core of the Article! Logical SummaryAs a master's student in clinical psychology, the author unravels the foresight of the sci-fi anime 'PSYCHO-PASS' and reveals the extremes and limitations of AI ...
A qualitative synthesis of 13 studies reveals how young people with eating disorders experience online content as simultaneously supportive and harmful.
The Department of Psychology at the University of Toronto Scarborough (UTSC) invites applications for a full-time tenure stream position in the area of Clinical Psychology.
Antipsychotics are used to treat schizophrenia, along with bipolar disorder and major depressive disorder. However, these medications can be associated with hyponatremia, a serious reduction in blood ...
As recreational ketamine use rises and researchers continue to explore ways the drug could help people in clinical settings, here’s a primer on this drug, its uses and its risks.
Theodore Wagener, PhD, discusses an Ohio State feasibility study testing psilocybin-assisted therapy for depression in patients with non–small cell lung cancer. Theodore Wagener, PhD, founding ...
A new experience-informed commentary argues that Peer Researchers with lived experience of eating disorders can only transform research if recruitment, welfare, power-sharing, training, and funding ...
I kept blaming myself, thinking, "It's because I'm not good enough."I myself have always had an "HSS-type HSP" temperament (a personality that seeks stimulation but is easily exhausted), and I have ...
The Center for OCD and Anxiety, which has four locations in the Pittsburgh region, uses social media, podcasts, community events, and other avenues to explain certain mental health conditions.
The Core of the Article! Logical SummaryFrom the intersection of clinical psychology and AI, Yasumi Kikuchi (Certified Psychologist) unravels the current state of AI clinical psychology. Now that AI's ...
Adolescents admitted to the hospital for eating disorders face increased readmission risks within the first year when they have certain clinical markers and demographic features.
A lived experience commentary in the Journal of Eating Disorders challenges 'treatment-resistant' and 'terminal' labels and proposes a five-principle recovery-fostering care ...
A new ketamine study suggests sleep and mood improvements may follow different patterns.
The Freeman-Burchfield Institute joins Good Day NWA to discuss OCD, common misconceptions, symptoms and ERP treatment.
Research by a team from the University of Glasgow has suggested that children whose mothers had depression during pregnancy were at higher risk of having special educational needs that couldn’t be ...
St. Joseph's Healthcare expands psychedelic medicine research, aiming to improve care for patients with treatment-resistant conditions.
Trickett Psychotherapy says cost should not force Ontarians to choose mental-health care by price instead of clinical fit ...
Equip, a leading provider of virtual, evidence-based eating disorder treatment in the U.S., today announced Equip Transition Track: an enhanced care protocol that allows medically stable patients with ...
Company Calls for Consideration of New Regulatory Pathways and Cost Saving of Non-Hallucinogenic Neuroplastogens for Alcohol Use Disorder Vancouver, Canada, Oct. 07, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: ...
Behavioral health experts say more research is needed to determine the true impact of GLP-1 drugs on eating disorders.
The possibility of psychedelic therapies for PTSD or treatment-resistant depression in the U.S. has never been greater. But even as the industry inches closer to an FDA go-ahead, the realities of ...
People suffering from depression who use psilocybin continue to utilize traditional mental health care at the same rates as nonusers, but they report significantly higher rates of ...
Most people do not arrive at mental health care with a clear plan in hand. Symptoms usually build slowly. Sleep gets worse, concentration slips, small tasks start to feel heavy, ...
A team of USC researchers has received an up to $4 million award from the Advanced Research Projects Agency for Health (ARPA-H) to conduct a clinical trial of psychedelic therapy and mindfulness ...
If treatment is no longer helping sufficiently, options can include adjusting the dose or switching antidepressants. A talking therapy may also help. This involves working with a trained therapist to ...
H-funded clinical trial testing whether an eight-week mindfulness training program can enhance and sustain the antidepressant effects of psilocybin therapy in 80 ...
Send a personal recommendation to a friend.